CA2190993C — Protective agent for organ or tissue
Assigned to Teijin Ltd · Expires 2004-06-01 · 22y expired
What this patent protects
An agent composition for the therapy or prevention of the injury of an organ or a tissue containing a phenylthiazole derivative expressed by the following formula (1): (R1 is a C1-C8 alkoxy group or a cyclic amino group; R2 is a cyano group or a nitro group; R3 is a hydroge…
USPTO Abstract
An agent composition for the therapy or prevention of the injury of an organ or a tissue containing a phenylthiazole derivative expressed by the following formula (1): (R1 is a C1-C8 alkoxy group or a cyclic amino group; R2 is a cyano group or a nitro group; R3 is a hydrogen atom or a C1-C4 alkyl group), and/or its salt as an active ingredient.
Drugs covered by this patent
- Uloric (FEBUXOSTAT) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.